#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fusarium infection Breast angiosarcoma metastatic Plasma cell myeloma recurrent Neonatal alloimmune thrombocytopenia Dedifferentiated liposarcoma Hyperadrenocorticism Hyperchylomicronaemia Liposarcoma Macular telangiectasia Mantle cell lymphoma Stargardt's disease Oesophageal adenocarcinoma stage II Colon cancer Mycobacterium abscessus infection Neurodermatitis More trials…

    Learn about Rare Diseases

    Lymphangioma – Treatment Mantle cell lymphoma stage II Leiomyosarcoma metastatic – Life with Disease Leukoencephalopathy – Treatment Isodicentric chromosome 15 syndrome – Diagnostics Osteosarcoma – Basic Information Andersen-Tawil syndrome Hereditary neuropathic amyloidosis – Treatment Pulmonary fibrosis Hereditary hypophosphataemic rickets – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Icosapent Ethyl Opevesostat Tosilate Elamipretide Trihydrochloride Linerixibat Human Coagulation Factor Viii Idarubicin Hydrochloride LUNSEKIMIG Pamapimod Rbl007.2 Viltolarsen Mk-1084 Tezacaftor Tipiracil Apl-101 Pozelimab Utreloxastat UDONITRECTAG Napabucasin Nimodipine ANXV More therapies…

    Learn about Your Condition

    Sinusitis bacterial Wheezing Choreoathetosis Monogenic diabetes Appendicitis perforated Pancreatic carcinoma stage IV Cervix carcinoma Hepatic fibrosis Oxygen saturation Weaning failure Dystonic tremor Bone marrow disorder Hypotension Migraine Chronic coronary syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of E7386 and Lenvatinib for Patients with Liver, Colon, Endometrial, or Other Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    • Colorectal cancer
    • Endometrial cancer
    Investigated Drugs:
    • (6S,9As)-8-((6-(3-(4-Ethyl-1-Piperazinyl)-1-Azetidinyl)-2-Pyridinyl)Methyl)-6-((2-Fluoro-4-Hydroxyphenyl)Methyl)Hexahydro-4,7-Dioxo-N-(Phenylmethyl)-2-(2-Propen-1-Yl)-2H-Pyrazino(2,1-C)(1,2,4)Triazine-1(6H)-Carboxamide
    • Doxorubicin Hydrochloride
    • Lenvatinib
    Denmark France Italy Spain

  • Study of EO2463, Lenalidomide, and Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Omp64
    • Omp65
    • Omp66
    France Italy Spain

  • Study on Long-Term Safety of Idursulfase-IT and Elaprase for Patients with Hunter Syndrome and Cognitive Impairment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Mucopolysaccharidosis II
    Investigated Drugs:
    • Idursulfase
    France

  • Study on Clopidogrel’s Effect in Preventing Systemic Sclerosis for Patients with Raynaud’s Phenomenon and Specific Immune Conditions

    Recruiting

    4 1 1
    Investigated Diseases:
    • Raynaud’s phenomenon
    Investigated Drugs:
    • Clopidogrel
    France

  • Study Comparing Buckberg and Del Nido Solutions for Heart Surgery in Patients with Cardiovascular Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Calcium Chloride
    • Magnesium Chloride
    • Potassium Chloride
    Spain

  • Study on Progesterone to Prevent Preterm Birth in Pregnant Women with Placenta Previa

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Placenta praevia
    Investigated Drugs:
    • Progesterone
    The Netherlands
Previous Page
1 … 436 437 438 439 440 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!